EMMA WICKER: Open Payments
NPI 1407335425 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,004 in 123 payments from 36 companies in 2025. Trend: 2023 $1,093 · 2024 $3,789 · 2025 $3,004
Food & beverage: $2,904Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $359 |
| Janssen Biotech, Inc. | 11 | $329 |
| Novartis Pharmaceuticals Corporation | 16 | $315 |
| Merck Sharp & Dohme LLC | 6 | $163 |
| PFIZER INC. | 6 | $159 |
| Daiichi Sankyo Inc. | 6 | $130 |
| Incyte Corporation | 6 | $127 |
| Blueprint Medicines Corporation | 1 | $122 |
| Genentech USA, Inc. | 5 | $114 |
| Eisai Inc. | 4 | $73 |
Products named: KEYTRUDA, Fabhalta, AYVAKIT, ENHERTU, CALQUENCE, KISQALI, DARZALEX, RYBREVANT.
Industry payments across LA — which companies pay providers there.
